Where AdaptHealth Stands With Analysts
Portfolio Pulse from Benzinga Insights
AdaptHealth (NASDAQ:AHCO) has received mixed analyst ratings in the last quarter, with 3 bullish, 3 somewhat bullish, and 3 indifferent ratings. The average 12-month price target for the company has decreased by 26.77% from $21.44 to $15.7. Analysts determine these ratings based on the company's future earnings potential and the predictability of its revenue streams.
June 27, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
AdaptHealth has received mixed analyst ratings, with the average 12-month price target decreasing by 26.77% from $21.44 to $15.7.
The mixed analyst ratings indicate uncertainty about the company's future performance. The significant decrease in the average price target suggests that analysts have lowered their expectations for the company's stock price, which could potentially impact investor sentiment and the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100